IRs are posed to play a key role in the management of men's health with the rise of procedures like PAE, as well as IR's demonstrated impact on the disease states that affect men, such as stroke and heart disease.
This June, IR Quarterly celebrates Men's Health Month by showcasing stories, procedures, tips and discussions from the IR community involving men's health, interventions and collaboration stories. Read through the stories below to learn more, and be sure to watch the June 5 congressional briefing on men's health.
-
1
-
2
Urology and IR
Interventional radiologist Ari J. Isaacson, MD, and urologist Matthew C. Raynor, MD, who work together at UNC Health, have collaborated on a program that offers prostate artery embolization (PAE) to treat benign prostatic hyperplasia (BPH)...
-
3
Featured abstract preview: TULSA-PRO offers new treatment option for prostate cancer
Transurethral ultrasound ablation is a promising treatment for prostate cancer, with better outcomes and fewer side effects than traditional treatment, according to 3-year outcomes from the follow-up study of the TULSA-PRO® Ablation Clinical Trial.
-
4
Solved on SIR Connect: Uretero-iliac arterial fistula
75 yo F with a history of SCC involving the urethra. The patient is post cystectomy, ileal conduit and pelvic chemoradiation in 2015. In late 2018, the patient had a left ureteral stricture and hydronephrosis managed by perc neph…
-
5
Opportunities for IRs in radiotheranostics
Radiotheranostics combines the diagnostic and therapeutic aspects of oncology practice into one paradigm
-
6
Four-year follow up of novel device shows strong safety and efficacy for minimally invasive treatment of Intermediate risk prostate cancer
The 4-year outcome of a study on Magnetic Resonance-guided Transurethral Ultrasound Ablation (TULSA) of the prostate reinforces the durable efficacy of the treatment, as well as the quality-of-life benefits for patients.
-
7
PAE continues to show success alleviating urinary tract symptoms from enlarged prostate
A large longitudinal study of 1,000 patients confirmed the effectiveness and safety of PAE for lower urinary tract symptoms (LUTS) and urinary retention caused by BPH, according to authors of this Abstract of the Year.
